A pharmaceutical molecule is transported to its target site via various strategies, formulations, production processes, storage systems, and technologies in order to provide the intended therapeutic effect. To maximize efficacy and safety, as well as to enhance patient comfort and compliance, principles relating to drug production, route of administration, site-specific targeting, metabolism, and toxicity are applied. By combining different excipients, drug carriers, and medical devices with a drug formulation, drug delivery aims to change a medication's pharmacokinetics and specificity. To enhance treatment results, there is an added focus on extending a drug's duration of action and bioavailability. The improvement of medicine administration personnel safety has also been the subject of some studies. To lower the danger of needlestick injuries, for instance, many kinds of microneedle patches have been created for giving vaccinations and other drugs. The idea of drug delivery is closely related to dose form and mode of administration; the latter is occasionally included in the definition. Although medication delivery and the route of administration are frequently used interchangeably, they are two different ideas. While drug delivery also includes the engineering of delivery systems and can comprise various dosage forms and devices used to administer medication through the same route, route of administration refers to the path a drug takes to enter the body. Oral, parenteral (injected), sublingual, topical, transdermal, inhalation, rectal, and vaginal modes, etc.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia